Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
URGN
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
URGN
$27.65
−12.86%
Lists
Call URGN
UroGen Pharma
URGN
Back
Lists
Call URGN
$27.65
−$4.08 · −12.86%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Down
41%
in three months and
32%
of the way up its 52-week range.
Call URGN
Loading chart data...
Signal state
URGN: UroGen Pharma Ltd. Stock Analysis | finqOS